Investor Relations

Welcome to the Investor Relations for Phase Holographic Imaging (PHI)

What’s New

Press Releases

October 18, 2024

PHI AB’s warrant exercise registered at the Swedish Companies Registration Office

Phase Holographic Imaging PHI AB (“PHI” or “Company”) today announces that the new shares from the exercise of warrants of series TO 4 have been registered at the Swedish Companies Registration Office.

1234…130

News featuring PHI

August 21, 2024

BioStock: PHI’s CEO comments on the approved US listing

PHI has been approved for a dual US listing in addition to its primary listing on the Swedish Spotlight market. What does this mean for the company’s shareholders, and how might it impact the company’s long-term valuation? BioStock reached out to PHI’s CEO Patrik Eschricht to discuss this and the upcoming redemption of the TO4 warrants that could potentially raise SEK 20.8 million in October.

1234…29

About PHI

Phase Holographic Imaging (PHI) develops and markets its non-invasive time-lapse imaging instruments. The company’s current HoloMonitor® products are globally used for long-term quantitative analysis of living cell cultures, particularly in preclinical research.

Now, PHI is actively focusing on business development. With unique solutions focused on Quantitative Phase Imaging (QPI) — a technology that brings a novel, cell-friendly approach to critical cell quality evaluation, PHI is expanding into the fast-growing regenerative medicine field.

PHI envisions transforming live cell analysis and establishing its QPI technology as a standard for cell quality control, making our future cell therapies safe, affordable, and accessible for patients. PHI is based in Lund, Sweden, Boston, MA and Winston-Salem, NC.

Investor Information

All Press Releases

Here you can read all PHI press releases.

Read Press Releases

Company News

Here you see PHI featured in news and CEO commentaries.

See Company News

Reports & Documents

Here you find PHI’s interim and annual reports, as well as view general meeting and emission documents.

Find Reports & Documents

Investor Q&A

Here you can browse the frequently asked investor questions and quickly find your answers.

Browse Investor Q&A

Any questions? Please get in touch with our CEO,
Patrik Eschricht, at: ir@phiab.com

Investor Calendar

Stock Information